Skip to content
Open access

Association Between the Number of Metabolic Syndrome Components and Markers of Subclinical Vascular Damage: A Retrospective Cross-Sectional Study

Aug 2026 · Journal of Clinical Medicine · Vol 15, pp. 6638 · 1 citation · 44 references
Medicine

TL;DR

The results do not support the use of a simple count of MetS components as an indicator of subclinical cardiovascular dysfunction related to atherosclerosis and AS, and most associations were explained by confounding variables.

Abstract

Background: Metabolic syndrome (MetS) refers to the coexistence of cardiometabolic disorders, such as hyperglycemia, elevated blood pressure, visceral obesity, or features of atherogenic dyslipidemia. A diagnosis of MetS significantly increases the risk of cardiovascular disease (CVD). However, the exact relationship between the number of MetS components, regardless of their constellation, and features of subclinical cardiovascular dysfunction remains unclear. This study aimed to explore the relationship between the number of MetS components and features of subclinical atherosclerosis and arterial stiffness (AS) in patients without clinically overt CVD. Methods: This retrospective study included 100 patients (mean age: 58.8 ± 16.81 years), without signs of acute illness or diagnosed atherosclerotic CVD, who were admitted to a clinic for scheduled internal medicine diagnostics. Participants were assessed for MetS components and underwent cardiovascular tests, including Doppler ultrasonography of the carotid, vertebral, and lower limb arteries; measurement of intima–media thickness (IMT) in the carotid (cIMT), common femoral (cfIMT), and superficial femoral (sfIMT) arteries; and assessment of AS using carotid–femoral pulse wave velocity (cfPWV) and pulse wave analysis (PWA). Results: Univariate analysis revealed significant correlations between the number of MetS components and IMT in all vascular beds: cIMT (R = 0.371; p < 0.001), cfIMT (R = 0.343; p < 0.001), and sfIMT (R = 0.516; p < 0.001). Significant correlations were also found for several AS and PWA parameters: cfPWV (R = 0.398; p < 0.001), central pulse pressure (cPP) (R = 0.223; p < 0.026), and end-systolic pressure (ESP) (R = 0.241; p = 0.016). Meanwhile, in the multivariable analysis adjusted for sex, age, and body mass index (BMI), only the association between the subendocardial viability ratio (SEVR) and the number of MetS components was significant (β = 0.33; 95% CI 0.084–0.577; p = 0.009); however, this association does not remain significant after Benjamini–Hochberg correction (p = 0.108). Conclusions: Although the number of MetS components correlated significantly with several parameters of subclinical atherosclerosis and AS, most associations were explained by confounding variables. These results do not support the use of a simple count of MetS components as an indicator of subclinical cardiovascular dysfunction related to atherosclerosis and AS.

Read PDF

Similar papers

Open access Oct 2026

Estimation of some Biochemical Markers in Patients with Metabolic Syndrome

A collection of metabolic disorders, such as central obesity, insulin resistance, hypertension, and dyslipidemia, are known as metabolic syndrome. Together, these variables raise the risk of atherosclerosis, type II diabetes, and cardiovascular illnesses. The prevalence of MetS is rising globally, especially in populat...

D. A. Kadhim · 0 citations
Open access Sep 2026

Association of Metabolic Risk Factors with Early Multiorgan Dysfunction in Adults without Diabetes or Hypertension

Background: Metabolic abnormalities can lead to injury to several organ systems early in the course of diabetes and hypertension. This study estimated the relationship between metabolic risk factors and early multiorgan dysfunction in adults without these known metabolic risk factors. Methods: An analytical cross-secti...

Habiba Inayat, Tariq Ahmad, Shahana Dawood et al. · 0 citations
Open access Oct 2026

Association of cardiovascular-kidney-metabolic syndrome with cardiovascular mortality: a prospective cohort study in Madeira Island

A high prevalence of CKM syndrome (stages 1 to 4) among the Madeira cohort population is revealed, and higher CKM stages were associated with an increased risk of cardiovascular mortality, and primordial and primary prevention efforts on promoting CKM health should be strengthened to reduce mortality risk.

F. Sousa, M. Mendonca, S. Freitas et al. · 0 citations
Sep 2026

Association of Cardiometabolic Index with Cardiometabolic Continuum Across Healthy, Type 2 Diabetes Mellitus and Cardiovascular Disease Groups in Rural South India.

Background: The Cardiometabolic index (CMI), a composite marker that combines atherogenic dyslipidemia, mainly triglyceride to high density lipoprotein cholesterol (TG/HDL-C) ratio, with central adiposity, is determined by the waist to height ratio (WHtR). The objective of this study was to examine the diagnostic perfo...

I. S · 0 citations
Open access Oct 2026

METABOLIC PROFILE AND PERIPHERAL ARTERIAL DISEASE-ASSOCIATED SYMPTOMS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL STUDY

Introduction: Peripheral arterial disease (PAD) is one of the most common macrovascular complications in patients with type 2 diabetes mellitus (T2DM). Previous international studies such as the UKPDS, ADVANCE, and ACCORD trials demonstrated a strong association between poor glycaemic control, cardiovascular risk and p...

Stojka Dokuzova · 0 citations
Review Open access Oct 2026

Cardiovascular-kidney-metabolic syndrome and type 2 diabetes mellitus: from risk stratification to multidisciplinary patient management

Type 2 diabetes mellitus (T2DM) is a key component of cardiovascular-kidney-metabolic (CKM) syndrome, an interconnected complex of metabolic disorders, chronic kidney disease (CKD), and cardiovascular disease (CVD). T2DM is characterized by chronic hyperglycemia resulting from insulin resistance and progressive impairm...

T. Demidova, M. Izmailova · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.